Home > Products > Featured products
Cat. No. Product name CAS No.
DC8846 HhAntag Featured

HhAntag is a GLI1-Mediated transcription inhibitor.

496794-70-8
DC7148 LY 379268 Featured

Highly selective group II mGlu receptor agonist (EC50 values are 2.69 and 4.48 nM for hmGlu2 and hmGlu3 respectively) that displays > 80-fold selectivity over group I and group III receptors.

191471-52-0
DC10585 Hispidol Featured

Hispidol ((Z)-Hispidol) is a potential therapeutic for inflammatory bowel disease; inhibits TNF-α induced adhesion of monocytes to colon epithelial cells with an IC50 of 0.50 µM.

5786-54-9
DC10171 Hispidulin Featured

Hispidulin is a natural flavone with a broad spectrum of biological activities. Hispidulin is a Pim-1 inhibitor with an IC50 of 2.71 μM.

1447-88-7
DCAPI1505 Darunavir Featured

Darunavir(TMC114) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2) .

206361-99-1
DC8163 Fostemsavir(BMS-663068) Featured

HIV-1 attachment inhibitor,a prodrug of the small-molecule inhibitor BMS-626529

864953-29-7
DC21116 HJC0197 Featured

HJC0197 is a potent Epac1 (exchange protein directly activated by cAMP 1) and Epac2 (IC50=5.9 μM for Epac2) antagonist. HJC0197 selectively blocks cAMP-induced Epac activation. HJC0197 inhibits Epac1-mediated Rap1-GDP exchange activity at 25 μM in the presence of equal concentration of cAMP.

1383539-73-8
DC7638 HJC-0350 Featured

HJC-0350 is a selective Epac2 inhibitor (IC50 = 0.3 μM). Displays no effect on Epac1. Blocks stimulation of the Epac2-FL FRET sensor in HEK293 cells.

885434-70-8
DC9678 HLCL-61 hydrochloride Featured

HLCL-61 is a first-in-class small-molecule inhibitor of PRMT5 for treatment of acute myeloid leukemia.

1158279-20-9
DC10414 HM30181(Encequidar) Featured

HM30181 is a potent and selective inhibitor of P-glycoprotein.

849675-66-7
DC12074 HM30181 mesylate Featured

HM30181 mesylate is a competitive and potent P-glycoprotein inhibitor.

849675-87-2
DC8819 Olmutinib (HM61713; BI-1482694) Featured

HM-61713 (BI-1482694) is an orally available small molecule, mutant-selective inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.

1353550-13-6
DC10517 HMN-154 Featured

HMN-154 is a novel benzenesulfonamide anticancer compound; inhibits KB and colon38 cells with IC50 values of 0.0026 and 0.003 μg/mL, respectively.

173528-92-2
DC9957 HMN-176 Featured

HMN-176 is a stilbene derivative which inhibits mitosis without significant effect on tubulin polymerization.

173529-10-7
DC8768 HMN-214 Featured

HMN-214(IVX214) is a potent PLK1 inhibitor an average IC50 of 0.12 μM.

173529-46-9
DC6314 Icatibant acetate Featured

HOE-140 (Icatibant) is a potent and selective bradykinin B2 receptor antagonist (pA2 = 9.04). Also inhibits aminopeptidase N (Ki = 9.1 μM).

138614-30-9
DC22129 HOIPIN-1(JTP-0819958;HOIP inhibitor-1) Featured

HOIPIN-1 (JTP-0819958, HOIP inhibitor-1) is a chemical inhibitor of linear ubiquitin chain assembly complex (LUBAC, IC50=2.8 uM), specifically generates Met1-linked linear ubiquitin chains through the ubiquitin ligase activity in HOIP, and activates the N

DC9650 Homoharringtonine Featured

Homoharringtonine(HHT) is a cytotoxic alkaloid from the evergreen tree.

26833-87-4
DC5908 Honokiol Featured

Honokiol(NSC-293100), a hydroxylated biphenyl compound isolated from the Chinese herb Magnolia officinalis, has been reported to have anticancer activities in a variety of cancer cell lines.

35354-74-6
DC7424 HPGDS-inhibitor-1 Featured

HPGDS inhibitor 1 is a novel and selective Hematopoietic Prostaglandin D Synthase (HPGDS) inhibitor with an IC50 Value of 0.7 nM.

1033836-12-2
DC23978 hPGDS-IN-1 Featured

hPGDS-IN-1 is a potent, selective hPGDS inhibitor with IC50 of 12 nM in FP or EIA assays..

1234708-04-3
DC23894 HPI-1 Featured

HPI-1 is a Hedgehog (Hh) pathway inhibitor that suppresses signaling through Shh (IC50=1.5 uM) without significantly affecting Wnt signaling (IC50>30 uM).

599150-20-6
Page 104 / Total 440 FirstPrevNextLastGoto